Intracerebral haemorrhage is the most serious complication of intravenous thrombolysis in ischaemic stroke, and whether thrombolysis can be performed in patients receiving anticoagulants is an unresolved issue. Data from a large European registry now confirms that thrombolysis in some patients receiving warfarin is as safe as in non-anticoagulated patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Adams, H. P. et al. Guidelines for the Early Management of Adults with Ischemic Stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 38, 1655–1711 (2007).
European Stroke Organisation (ESO) Executive Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis. 25, 457–507 (2008).
Mazya, M. V. et al. Safety of IV thrombolysis for ischemic stroke in patients treated with warfarin. Ann. Neurol. http://doi.dx.org/10.1002/ana.23924.
Xiang, Y. et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA 307, 2600–2608 (2012).
Diener, H. C. et al. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment. Lancet Neurol. 12, 677–688 (2013).
Frank, B. et al. Thrombolysis in stroke despite contraindications or warnings? Stroke 44, 727–733 (2013).
Rizos, T. et al. Oral anticoagulants—a frequent challenge for the emergency management of acute ischemic stroke. Cerebrovasc. Dis. 34, 411–418 (2012).
Gladstone. et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 40, 235–240 (2009).
Rizos, T. et al. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants. Stroke 40, 3547–3551 (2009).
Sun, L., Zhou, W., Ploen, R., Zorn, M. & Veltkamp, R. Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia. Thromb. Haemost. 110, 153–161 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R. Veltkamp has received consulting fees from Boehringer Ingelheim, Bayer, BMS/Pfizer and Roche; research support from Bayer and Boehringer Ingelheim; and speaker's honoraria from Bayer, Boehringer Ingelheim, BMS/Pfizer, Roche, Apoplex Medical Technologies and CSL Behring. T. Rizos declares no competing interests.
Rights and permissions
About this article
Cite this article
Veltkamp, R., Rizos, T. Is thrombolysis safe in anticoagulated ischaemic stroke?. Nat Rev Neurol 9, 492–493 (2013). https://doi.org/10.1038/nrneurol.2013.159
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2013.159
